Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yan Helen Hu

Showing results (1-10 of 6) with videos related to

Pageof 1
Sort By:
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|December 25, 2025
BiomarkersYan Helen Hu, Elizabeth Somers, Miyuru Amarapala, et al.
Alzheimer'S & Dementia (Amsterdam, Netherlands)|July 24, 2024
Plasma pTau181 enhances the prediction of future clinical decline in amyloid-positive mild cognitive impairmentViswanath Devanarayan, Daniel A Llano, Yan Helen Hu, et al.
Neurology. Clinical Practice|December 25, 2025
Advancing Early Detection of Alzheimer Disease in the Primary Care Setting in the United StatesMichelle M Mielke, H Ricky Kurzman, Yan Helen Hu, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|October 6, 2024
Considerations for widespread implementation of blood-based biomarkers of Alzheimer's diseaseMichelle M Mielke, Matthew Anderson, J Wesson Ashford, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|October 1, 2024
Recommendations for clinical implementation of blood-based biomarkers for Alzheimer's diseaseMichelle M Mielke, Matthew Anderson, J Wesson Ashford, et al.
Nature Reviews. Neurology|June 12, 2024
Acceptable performance of blood biomarker tests of amyloid pathology - recommendations from the Global CEO Initiative on Alzheimer's DiseaseSuzanne E Schindler, Douglas Galasko, Ana C Pereira, et al.
Pageof 1

Showing results (1-10 of 6) with videos related to

Sort By:
Pageof 1
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|December 25, 2025
BiomarkersYan Helen Hu, Elizabeth Somers, Miyuru Amarapala, et al.
Alzheimer'S & Dementia (Amsterdam, Netherlands)|July 24, 2024
Plasma pTau181 enhances the prediction of future clinical decline in amyloid-positive mild cognitive impairmentViswanath Devanarayan, Daniel A Llano, Yan Helen Hu, et al.
Neurology. Clinical Practice|December 25, 2025
Advancing Early Detection of Alzheimer Disease in the Primary Care Setting in the United StatesMichelle M Mielke, H Ricky Kurzman, Yan Helen Hu, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|October 6, 2024
Considerations for widespread implementation of blood-based biomarkers of Alzheimer's diseaseMichelle M Mielke, Matthew Anderson, J Wesson Ashford, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|October 1, 2024
Recommendations for clinical implementation of blood-based biomarkers for Alzheimer's diseaseMichelle M Mielke, Matthew Anderson, J Wesson Ashford, et al.
Nature Reviews. Neurology|June 12, 2024
Acceptable performance of blood biomarker tests of amyloid pathology - recommendations from the Global CEO Initiative on Alzheimer's DiseaseSuzanne E Schindler, Douglas Galasko, Ana C Pereira, et al.
Pageof 1